A Study Investigating the Clinical Parameters Associated With the Use of Ryzodeg® (Insulin Degludec/Insulin Aspart) in a Real-world Adult Population With Type 2 Diabetes in South Korea
Clinical trial NCT04656106 · COMPLETED
Trial details
- NCT number
- NCT04656106
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-27
- Primary completion
- 2021-07-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.